Eisenbeis, Charles F <br/><br/>
Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2004 
 - 6101-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-04-0525  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--administration & dosage<br/>Combined Modality Therapy--methods<br/>Female<br/>Humans<br/>Immunotherapy--methods<br/>Interleukin-2--administration & dosage<br/>Killer Cells, Natural--immunology<br/>Leukocytes--immunology<br/>Leukocytes, Mononuclear--metabolism<br/>Lymphoma, B-Cell--immunology<br/>Lymphoma, Non-Hodgkin--immunology<br/>Male<br/>Mice<br/>Mice, SCID<br/>Middle Aged<br/>Rituximab<br/>Time Factors<br/>Treatment Outcome